Alcoholic liver disease (ALD) is a global public health challenge due to the high incidence
and lack of effective therapeutics. Evidence from animal studies and ALD patients has …

Non‑alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases
and can lead to liver cirrhosis or liver cancer in severe cases. In recent years, the incidence …

Nonalcoholic fatty liver disease (NAFLD), tightly linked to the metabolic syndrome (MS), has
emerged as a leading cause of chronic liver disease worldwide. Since it is potentially …

Icariin, a flavonoid abundant in the herb Epimedium, exhibits anti-ferroptotic activity.
However, its impact on nonalcoholic steatohepatitis (NASH) development remains unclear …

Iron deposition and chronic inflammation are associated with chronic liver diseases, such as
alcoholic liver disease, nonalcoholic fatty liver disease, and chronic hepatitis B and C …

Simple Summary In children after intensive chemotherapy for acute leukemias (AL) or
undergoing hematopoietic cell transplantation (HCT), the prognostic impact of 12 serum iron …

Hyperglycemia is an independent risk factor for the rapid progression of nonalcoholic
steatohepatitis (NASH) to liver fibrosis with an incompletely defined mechanism. Ferroptosis …

Microcystins (MCs) produced by cyanobacteria are potent toxins to humans that cannot be
ignored. However, the toxicity of MCs to humans remains largely unknown. The study …

Hyperferritinemia, observed in inflammation, iron overload as well as in combination of both,
is found in∼ 30% of nonalcoholic fatty liver disease (NAFLD) patients. The authors …

Chronic liver disease (CLD) is a major health problem worldwide. Non-alcoholic fatty liver
disease (NAFLD), chronic hepatitis C (CHC), chronic hepatitis B (CHB), and alcoholic liver …